Alimera Sciences Inc (ALIM)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current ALIM market cap is 301.29M. The company's latest EPS is USD -0.3933 and P/E is -14.09.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 17.54M | 23.36M | 26.31M | 23.01M | 27M |
| Operating Income | -1.21M | 1.85M | 724k | -2.3M | -77k |
| Net Income | -10.7M | -1.77M | -3.94M | -6.25M | -3.31M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 53.94M | 50.82M | 59.03M | 54.13M | 80.75M |
| Operating Income | -5.27M | -501k | -201k | -11.64M | -1.93M |
| Net Income | -10.44M | -5.34M | -4.37M | -18.11M | -21.39M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 154.92M | 154.19M | 153.52M | 152.49M | 150.38M |
| Total Liabilities | 108.69M | 105.35M | 107.35M | 111.83M | 111.59M |
| Total Equity | 46.23M | 48.84M | 46.17M | 40.65M | 38.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 50.31M | 50.86M | 58.52M | 42.6M | 153.52M |
| Total Liabilities | 54.75M | 58.83M | 61.13M | 63.41M | 107.35M |
| Total Equity | -4.45M | -7.98M | -2.61M | -20.81M | 46.17M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.21M | -18.03M | -14.26M | -566k | 460k |
| Investing | -75.44M | -75.45M | -75.53M | -21k | -132k |
| Financing | 97.12M | 96.58M | 96.5M | 2.97M | -1.35M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.15M | -2.19M | -3.22M | -9.98M | -14.26M |
| Investing | -174k | -620k | -621k | -255k | -75.53M |
| Financing | 869k | 3.88M | 9.82M | -302k | 96.5M |
| Market Cap | 301.29M |
| Price to Earnings Ratio | -14.09 |
| Price to Sales Ratio | 3.73 |
| Price to Cash Ratio | 24.99 |
| Price to Book Ratio | 6.53 |
| Dividend Yield | - |
| Shares Outstanding | 54.38M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 1.75M |
| 52 Week Change | 81.05% |
| 52 Week High | 5.65 |
| 52 Week Low | 2.60 |
| Spread (Intraday) | 0.51 (9.14%) |
| Company Name | Alimera Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.alimerasciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
